OpenAI's New AI Model Could Cut Drug Discovery Time in Half

OpenAI just launched GPT-Rosalind, an AI model designed to speed up the painfully slow process of bringing new medicines to patients.

Major pharma companies like Moderna and Amgen are already putting it to work.